[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@AppieAnanas](/creator/twitter/AppieAnanas) "$PRQR Oct investor conferences may quietly preview new Axiomer CNS data (AX-0810 / Rett). Some slides likely overlap with Eli Lilly-linked targets under NDA shared only with institutions. What do you think Theres something bubbling anyway" [X Link](https://x.com/AppieAnanas/status/1978078857061118327) [@AppieAnanas](/creator/x/AppieAnanas) 2025-10-14T12:42Z XX followers, XXX engagements "@SelsoftDataFlow X is a nice rest stop on the climb to the top if everything goes well" [X Link](https://x.com/AppieAnanas/status/1978476577382920497) [@AppieAnanas](/creator/x/AppieAnanas) 2025-10-15T15:02Z XX followers, XX engagements "@SelsoftDataFlow If ProQRs Rett NHP data confirm safe and efficient CNS RNA editing Eli Lilly gains a strong incentive to acquire not just partner to lock down the Axiomer platform and accelerate its own neuro pipeline. $PRQR" [X Link](https://x.com/AppieAnanas/status/1978481381660651901) [@AppieAnanas](/creator/x/AppieAnanas) 2025-10-15T15:21Z XX followers, XXX engagements "Pipeline & CNS expansion AX-0810 (NTCP): CTA submitted Phase X starts Q4 AX-2402 (Rett syndrome): first CNS program backed by NHP data Lilly partnership: X undisclosed targets ProQR shows CNS ambitions beyond Lilly potential second-wave value once functional data emerge" [X Link](https://x.com/AppieAnanas/status/1980568444526551542) [@AppieAnanas](/creator/x/AppieAnanas) 2025-10-21T09:34Z XX followers, XX engagements "Only two companies now have endogenous ADAR RNA-editing platforms entering the clinic: ProQR Therapeutics ($PRQR) Wave Life Sciences ($WVE) Both recruit the bodys own ADAR enzyme no viral delivery no foreign proteins. The cleanest form of RNA correction. #RNAediting" [X Link](https://x.com/AppieAnanas/status/1980569307395559667) [@AppieAnanas](/creator/x/AppieAnanas) 2025-10-21T09:38Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AppieAnanas
"$PRQR Oct investor conferences may quietly preview new Axiomer CNS data (AX-0810 / Rett). Some slides likely overlap with Eli Lilly-linked targets under NDA shared only with institutions. What do you think Theres something bubbling anyway"
X Link @AppieAnanas 2025-10-14T12:42Z XX followers, XXX engagements
"@SelsoftDataFlow X is a nice rest stop on the climb to the top if everything goes well"
X Link @AppieAnanas 2025-10-15T15:02Z XX followers, XX engagements
"@SelsoftDataFlow If ProQRs Rett NHP data confirm safe and efficient CNS RNA editing Eli Lilly gains a strong incentive to acquire not just partner to lock down the Axiomer platform and accelerate its own neuro pipeline. $PRQR"
X Link @AppieAnanas 2025-10-15T15:21Z XX followers, XXX engagements
"Pipeline & CNS expansion AX-0810 (NTCP): CTA submitted Phase X starts Q4 AX-2402 (Rett syndrome): first CNS program backed by NHP data Lilly partnership: X undisclosed targets ProQR shows CNS ambitions beyond Lilly potential second-wave value once functional data emerge"
X Link @AppieAnanas 2025-10-21T09:34Z XX followers, XX engagements
"Only two companies now have endogenous ADAR RNA-editing platforms entering the clinic: ProQR Therapeutics ($PRQR) Wave Life Sciences ($WVE) Both recruit the bodys own ADAR enzyme no viral delivery no foreign proteins. The cleanest form of RNA correction. #RNAediting"
X Link @AppieAnanas 2025-10-21T09:38Z XX followers, XX engagements
/creator/twitter::1869742496902692864/posts